Home

MPM BioImpact reported a 16.4% stake in Context Therapeutics CNTX · 14,705,882 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
16.4%
Last report
First report
Shares held
14,705,882 sh
Class
Common Stock, par value $0.001 per share
Event date
24/12/31
Filed
25/01/08

First 5%+ report · 16.4% stake

Context Therapeutics trades, last 26 weeks

What else happened in Context Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/01~25/01/30

MPM BioImpact's other 5% stake reports

  • MPM BioImpact

    5% stakeContext Therapeutics

    1.4% stake

    Filed 08/14

  • MPM BioImpact

    5% stakeDBV Technologies

    6.2% stake

    Filed 08/14

  • MPM BioImpact

    5% stakeClimb Bio

    0% stake

    Filed 08/14

  • MPM BioImpact

    5% stakeDBV Technologies

    8.8% stake

    Filed 05/15

  • MPM BioImpact

    5% stakeDBV Technologies

    9.9% stake

    Filed 02/17